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Aberrant lipid metabolism, central to atherosclerosis, is mechanistically influenced by insulin resistance and nonalcoholic fatty liver disease (NAFLD), which favors production and secretion of large very low-density lipoprotein (VLDL) particles from the liver(1). These large VLDL particles are slowly metabolized in the periphery, leading to formation of atherogenic small dense low-density lipoprotein (sdLDL) particles(2).